Bli medlem
Bli medlem

Du är här

2016-11-14

Alligator Bioscience: Alligator Bioscience AB publishes prospectus for Initial Public Offering on Nasdaq Stockholm

Press release, November 14, 2016

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY,
IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY
OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION
WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.

Alligator Bioscience AB ("Alligator" or the "Company"), a leading
biotech company developing innovative immune activating antibody
drugs for tumor-directed immunotherapy, announced on November 2, 2016
its intention to list the Company's shares on Nasdaq Stockholm.
Today, the Company publishes the prospectus for the offering (the
"Offering").

For more information, see http://alligatorbioscience.se/en/news/

-----------------------------------------------------------
http://feed.ne.cision.com/client/waymaker1/WOLReleaseFile.aspx?id=376025...
http://mb.cision.com/Main/12681/2121725/589119.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.